首页 | 本学科首页   官方微博 | 高级检索  
检索        


Inosiplex enhances the growth of Epstein-Barr nuclear antigen-positive B-cells from patients with rheumatoid arthritis and infectious mononucleosis
Authors:H Becker  K Helmke
Institution:1. School of Medicine, Federal University of Cariri, UFCA, Barbalha, Ceará, Brazil;2. Center for Biological and Health Sciences, Regional University of Cariri, URCA, Crato, Brazil;3. Ceará Cancer Institute, ICC, Fortaleza, Ceará, Brazil;1. Department of Physics, JNN College of Engineering, Shivamogga 577 204, Karnataka, India;2. Department of PG Studies and Research in Physics, Government Science College, Chitradurga 577 501, Karnataka, India;3. Department of Electronic Engineering, Institute for Wearable Convergence Electronics, Kyung Hee University, 1732 Deogyeong-daero, Giheung-gu, Yongin 17104, Republic of Korea;4. Department of Electrical and Electronics Engineering Science, University of Johannesburg, Auckland Park Campus, Johannesburg 2006, South Africa
Abstract:The in vitro effects of inosiplex (INO) on proliferation of Epstein-Barr virus (EBV)-carrying B-cells were evaluated. As measured by 3H-thymidine uptake, INO significantly augmented the proliferation of long-term cultured Epstein-Barr nuclear antigen (EBNA)-positive B-cells which were obtained from patients with rheumatoid arthritis (RA) and infectious mononucleosis (IM). In co-culture experiments, INO and anti-immunoglobulin M antibodies coupled to sepharose (anti-mu) had additive effects on proliferation of EBNA-positive B-cells. We conclude that its direct effects on B-cell function should be considered when INO is used for the treatment of diseases characterized by B-cell hyperreactivity.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号